DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF ELVITEGRAVIR IN PHARMACEUTICAL DOSAGE FORMS

Purchase PDF

Published: 2017-08-12

Page: 12-20


A. SUNEETHA *

Department of Pharmaceutical Analysis, Faculty of Pharmacy, Hindu College of Pharmacy, Amaravathi Road, Guntur-522 002, AP, India

G. BHAVANA

Department of Pharmaceutical Analysis, Faculty of Pharmacy, Hindu College of Pharmacy, Amaravathi Road, Guntur-522 002, AP, India

JACINTH ROOPU

Department of Pharmaceutical Analysis, Faculty of Pharmacy, Hindu College of Pharmacy, Amaravathi Road, Guntur-522 002, AP, India

*Author to whom correspondence should be addressed.


Abstract

The stability-indicating RP-HPLC method was developed and validated for quantitative determination of Elvitegravir in pharmaceutical dosage forms. An isocratic RP-HPLC method was developed with Luna C18 (250 mm x 4.6 mm, 5 µm) column and the mobile phase composed of 60 volumes of water and 40 volumes of acetonitrile mixture. The flow rate of the mobile phase was 1.2 mL min−1. Detection wavelength was 258 nm and ambient column temperature was maintained. The method was validated with regard to linearity, accuracy, precision, selectivity, and robustness. The drug was subjected to stress conditions of hydrolysis (acid and base), oxidation, photolysis and thermal degradation as per International Conference on Harmonization (ICH) prescribed stress conditions to show the stability-indicating power of the method.

Keywords: High performance liquid chromatography, Elvitegravir, validation


How to Cite

SUNEETHA, A., BHAVANA, G., & ROOPU, J. (2017). DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF ELVITEGRAVIR IN PHARMACEUTICAL DOSAGE FORMS. Journal of International Research in Medical and Pharmaceutical Sciences, 12(1), 12–20. Retrieved from https://ikprress.org/index.php/JIRMEPS/article/view/3523

Downloads

Download data is not yet available.